Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sufentanil dose and stress/awakening quality in pediatric laryngeal mask anesthesia for bronchoscopy
ChiCTR2500110675Phase 4Not yet recruiting
- Sponsor
- Shandong Provincial Third Hospital
- Start
- Oct 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of sufentanil (3 arms), sponsored by Shandong Provincial Third Hospital. Primary endpoints: Vital signs of children at each time point and Quality of child patient's awakening. Planned start Oct 2025; status: not yet recruiting.
02
Drugs
sufentanil
Beyond the preview
Go deeper on ChiCTR2500110675.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500110675.